Seeking Alpha

MSTX
  Mast Therapeutics, Inc. - NYSEMKT

11/26/2014, 10:30 AM ET
  • NoviceInvestor1 | Send Message 28 Feb

    $MSTX Vista Partners upgrades price target to 2.25
    Reply (2)
    • CWG0816 | Send Message 28 Feb
      : Great news.
    • dannyusf | Send Message 28 Feb
      : Real nice news, but don't think it will make a run like $RNN did when they got the 2.5$ PT unfortunately :(
      MSTX vs. ETF Alternatives
      Company Description
      Mast Therapeutics Inc is a biopharmaceutical company developing novel therapies for serious or life-threatening diseases with significant unmet needs. Its pipeline includes MST-188 development programs in adjunctive thrombolytic therapy.
      Sector: Healthcare
      Industry: Biotechnology
      Country: United States